| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 20 |
| 1 | PREDNISOLONE | 19 |
| 2 | PREDNISOLONE ORAL | 19 |
| 3 | PREDNISOLONE ORAL SOLUTION | 19 |
| 4 | OLMESARTAN MEDOXOMIL | 15 |
| 5 | CHOLESTYRAMINE | 13 |
| 6 | VEDOLIZUMAB | 13 |
| 7 | CEFUROXIME | 12 |
| 8 | HYDROCORTISONE | 12 |
| 9 | IPILIMUMAB | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROBENECID AND COLCHICINE | 1 | 0.0098 |
| 1 | CHOLESTYRAMINE | 13 | 0.0011 |
| 2 | CEFUROXIME | 12 | 0.0010 |
| 3 | TOFACITINIB CITRATE | 11 | 0.0008 |
| 4 | SIROLIMUS | 6 | 0.0004 |
| 5 | OLMESARTAN MEDOXOMIL | 15 | 0.0004 |
| 6 | OCTREOTIDE ACETATE | 12 | 0.0004 |
| 7 | ALEMTUZUMAB | 6 | 0.0003 |
| 8 | IPILIMUMAB | 12 | 0.0003 |
| 9 | MYCOPHENILIC ACID | 5 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Somatostatin Analog [EPC] | 8 | 0.0012 |
| 1 | Bile Acid Sequestrant [EPC] | 13 | 0.0011 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 6 | 0.0003 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 12 | 0.0002 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 5 | 0.0002 |
| 5 | Integrin Receptor Antagonist [EPC] | 13 | 0.0001 |
| 6 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 12 | 0.0001 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 12 | 0.0001 |
| 8 | Fluoroquinolone Antibacterial [EPC] | 11 | 0.0001 |
| 9 | Janus Kinase Inhibitor [EPC] | 11 | 0.0001 |